Celastrus orbiculatus Extract Inhibits Immune Inflammatory Thrombotic State of B-Lymphoma
Chinese Journal of Integrative Medicine · 2024
DOI: 10.1007/s11655-024-4102-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, 2024. Verfasst von Miao Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, 225001, China. Hauptthemen laut MEDLINE: Plant Extracts, Mice, Inbred BALB C, Thrombosis, Celastrus. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To investigate the inhibitory effect of Celastrus orbiculatus extracts (COE) on the proliferation of lymphoma cells and the immune regulation ability on inflammation and thrombophilia in vivo. METHODS: The 38B9 lymphoma cells were treated with COE (160 µ g/mL) and CTX (25 µ mol/L). The apoptosis rate and cell cycle of each group were detected by flow cytometry. The secretion of inflammatory factors, including interleukin (IL)-6, IL-10, and tumor necrosis factor α (TNF-α), in cell supernatant was detected by enzyme-linked immunosorbent assay (ELISA). In vivo, BALB/c mice were subcutaneously injected with 38B9 lymphoma cells to establish lymphoma model. COE (3 mg·kg-1·d-1) and CTX (40 mg·kg-1·d-1) were administered to the model mice, respectively. The expression of plasma inflammatory factors (IL-6, IL-10 and TNF-α) and thrombus indexes, including D-dimer (D-D), von Willebrand factor (vWF) and tissue factor (TF), were detected by ELISA before tumor bearing (1 d), after tumor formation (14 d) and after intervention (21 d). PicoGreen dsDNA was used to detect the level of serum neutrophil extracellular traps (NETs). Flow cytometry was used to detect the expression of platelet activation marker calcium-dependent lectin-like receptor 2 (CLEC-2). The tumor growth and survival of mice were recorded. RESULTS: The 38B9 lymphoma cells were apoptotic after the intervention of COE and CTX. The ratio of G2-M phase cells decreased in COE intervented cells compared with the control cells (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, 225001, China.
- Yangzhou Institute of Hematology, Yangzhou, Jiangsu Province, 225001, China.
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, 221000, China.
- Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu Province, 225001, China.
- Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, 210000, China. guhao1980@126.com.
Zitieren
APA
Zhu, M., Shi, Q. Q., Ni, J., Wu, W., Sun, X., Sun, M., Xu, K. L., Liu, Y. Q., Gu, J., & Gu, H. (2024). Celastrus orbiculatus Extract Inhibits Immune Inflammatory Thrombotic State of B-Lymphoma. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-024-4102-0
Vancouver
Zhu M, Shi QQ, Ni J, Wu W, Sun X, Sun M, et al. Celastrus orbiculatus Extract Inhibits Immune Inflammatory Thrombotic State of B-Lymphoma. Chinese Journal of Integrative Medicine. 2024. doi:10.1007/s11655-024-4102-0
BibTeX
@article{Zhu2024,
author = {Zhu, Miao and Shi, Qing-Qing and Ni, Jun and Wu, Wei and Sun, Xing and Sun, Mei and Xu, Kai-Lin and Liu, Yan-Qing and Gu, Jian and Gu, Hao},
title = {Celastrus orbiculatus Extract Inhibits Immune Inflammatory Thrombotic State of B-Lymphoma},
journal = {Chinese Journal of Integrative Medicine},
year = {2024},
doi = {10.1007/s11655-024-4102-0}
}
EUVIMED